Image: Shutterstock
FDA delays Moderna RSV vaccine decision, but what's next is likely to be a tougher, longer climb
The FDA has delayed the PDUFA date for Moderna’s RSV vaccine, the company announced Friday morning.
The delay likely won’t push …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
